Pfeiffer Manuela, Kirscht Susanne, Stumm Ralf, Koch Thomas, Wu Daifei, Laugsch Magdalena, Schröder Helmut, Höllt Volker, Schulz Stefan
Department of Pharmacology and Toxicology, Otto-von-Guericke University, 39120 Magdeburg, Germany.
J Biol Chem. 2003 Dec 19;278(51):51630-7. doi: 10.1074/jbc.M307095200. Epub 2003 Oct 7.
The micro-opioid receptor (MOR1) and the substance P receptor (NK1) coexist and functionally interact in nociceptive brain regions; however, a molecular basis for this interaction has not been established. Using coimmunoprecipitation and bioluminescence resonance energy transfer (BRET), we show that MOR1 and NK1 can form heterodimers in HEK 293 cells coexpressing the two receptors. Although NK1-MOR1 heterodimerization did not substantially change the ligand binding and signaling properties of these receptors, it dramatically altered their internalization and resensitization profile. Exposure of the NK1-MOR1 heterodimer to the MOR1-selective ligand [D-Ala2,Me-Phe4,Gly5-ol]enkephalin (DAMGO) promoted cross-phosphorylation and cointernalization of the NK1 receptor. Conversely, exposure of the NK1-MOR1 heterodimer to the NK1-selective ligand substance P (SP) promoted cross-phosphorylation and cointernalization of the MOR1 receptor. In cells expressing MOR1 alone, beta-arrestin directs the receptors to clathrin-coated pits, but does not internalize with the receptor. In cells expressing NK1 alone, beta-arrestin internalizes with the receptor into endosomes. Interestingly, in cells coexpressing MOR1 and NK1 both DAMGO and SP induced the recruitment of beta-arrestin to the plasma membrane and cointernalization of NK1-MOR1 heterodimers with beta-arrestin into the same endosomal compartment. Consequently, resensitization of MOR1-dependent receptor functions was severely delayed in coexpressing cells as compared with cells expressing MOR1 alone. Together, our findings indicate that MOR1 by virtue of its physical interaction with NK1 is sequestered via an endocytotic pathway with delayed recycling and resensitization kinetics.
微阿片受体(MOR1)和P物质受体(NK1)在伤害性感受脑区共存并在功能上相互作用;然而,这种相互作用的分子基础尚未确立。利用免疫共沉淀和生物发光共振能量转移(BRET)技术,我们发现MOR1和NK1在共表达这两种受体的HEK 293细胞中可形成异二聚体。虽然NK1-MOR1异二聚化并未显著改变这些受体的配体结合和信号传导特性,但却极大地改变了它们的内化和再敏化特征。将NK1-MOR1异二聚体暴露于MOR1选择性配体[D-丙氨酸2,甲基苯丙氨酸4,甘氨酸5-醇]脑啡肽(DAMGO)可促进NK1受体的交叉磷酸化和共内化。相反,将NK1-MOR1异二聚体暴露于NK1选择性配体P物质(SP)可促进MOR1受体的交叉磷酸化和共内化。在单独表达MOR1的细胞中,β-抑制蛋白将受体导向网格蛋白包被小窝,但不与受体一起内化。在单独表达NK1的细胞中,β-抑制蛋白与受体一起内化进入内体。有趣的是,在共表达MOR1和NK1的细胞中,DAMGO和SP均可诱导β-抑制蛋白募集到质膜,并使NK1-MOR1异二聚体与β-抑制蛋白共内化进入同一内体区室。因此,与单独表达MOR1的细胞相比,共表达细胞中MOR依赖性受体功能的再敏化严重延迟。总之,我们的研究结果表明,MOR1通过与NK1的物理相互作用,通过内吞途径被隔离,其再循环和再敏化动力学延迟。